Uncategorized
Update on MIGS: Devices of the Future
On June 25, 2012, after more than a decade of
development and clinical evaluation, the iStent
(Glaukos Corporation) received FDA approval
for the management of mild to moderate openangle
glaucoma at the time of cataract surgery. This widely
a...